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Steric regulation of tandem calponin homology 
domain actin-binding affinity
ABSTRACT Tandem calponin homology (CH1–CH2) domains are common actin-binding 
domains in proteins that interact with and organize the actin cytoskeleton. Despite regions of 
high sequence similarity, CH1–CH2 domains can have remarkably different actin-binding prop-
erties, with disease-associated point mutants known to increase as well as decrease affinity for 
F-actin. To investigate features that affect CH1–CH2 affinity for F-actin in cells and in vitro, we 
perturbed the utrophin actin-binding domain by making point mutations at the CH1–CH2 in-
terface, replacing the linker domain, and adding a polyethylene glycol (PEG) polymer to CH2. 
Consistent with a previous model describing CH2 as a steric negative regulator of actin bind-
ing, we find that utrophin CH1–CH2 affinity is both increased and decreased by modifications 
that change the effective “openness” of CH1 and CH2 in solution. We also identified interface 
mutations that caused a large increase in affinity without changing solution “openness,” sug-
gesting additional influences on affinity. Interestingly, we also observe nonuniform subcellular 
localization of utrophin CH1–CH2 that depends on the N-terminal flanking region but not on 
bulk affinity. These observations provide new insights into how small sequence changes, such 
as those found in diseases, can affect CH1–CH2 binding properties.
INTRODUCTION
Actin filaments are organized into diverse cytoskeletal structures by 
a wide range of actin-binding proteins (Michelot and Drubin, 2011; 
Harris et al., 2018). Tandem calponin homology (CH1–CH2) do-
mains are common actin-binding motifs found in diverse proteins, 
including the actin cross-linkers α-actinin and filamin, as well as the 
membrane–actin linkers utrophin (utrn) and dystrophin (Bañuelos 
et al., 1998; Korenbaum and Rivero, 2002). Despite a conserved 
structural fold (Gimona et al., 2002) and regions of high sequence 
conservation (∼20% identity and ∼30% conservation across the 
tandem domain, Figure 1A), different CH1–CH2 domains bind to 
filamentous actin (F-actin) with affinities that can vary between 
closely related proteins by as much as an order of magnitude. For 
example, the affinity of α-actinin-1′s actin-binding domain (ABD) 
has Kd = 4 µM (Winder et al., 1995), while that of α-actinin-4′s ABD 
is > 50 µM (Lee et al., 2008). Similarly, filamin A’s ABD has Kd = 47 µM 
(Ruskamo and Ylänne, 2009) compared with 7 µM for filamin B’s 
ABD (Sawyer et al., 2009), and utrophin’s ABD has Kd = 19 µM com-
pared with 44 µM for the ABD of its muscle homologue dystrophin 
(Winder et al., 1995).
The ability of small differences in sequence to have a significant 
impact on function is particularly clear in disease-associated CH1–
CH2 mutations. Mutations to the CH1–CH2 domain of α-actinin-4 
are associated with focal segmental glomerulosclerosis, a kidney 
disorder (Weins et al., 2007; Ehrlicher et al., 2015; Feng et al., 2018), 
while mutations to the CH1–CH2 domain of filamin’s isoforms and 
dystrophin are associated with skeletal dysplasia (Krakow et al., 
2004; Clark et al., 2009), muscular dystrophy (Norwood et al., 2000), 
and the migratory disorder periventricular nodular heterotopia 
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FIGURE 1: Measurement of bound fraction in live cells correlates with binding affinity in vitro. 
(A) Ribbon diagram of the actin-binding domain of utrophin (1QAG), colored for sequence 
similarity between utrophin, filamin, and plectin from blue to red. (B) Open and closed 
conformation of CH1–CH2 from the actin-binding domain of utrophin (1QAG, open) and the 
actin-binding domain of plectin (1MB8, closed). (C) Method for quantifying the relative bound 
fraction of proteins using live-cell imaging. Example images for the actin-binding domain of 
filamin A. The WT utrophin ABD channel is used to generate masks for the whole cell, for 
protein bound to actin, and for unbound protein, which are then used to calculate intensities in 
the CH1–CH2 channel of filamin A (bottom row, scale bar 20 µm). (D) Relative bound fraction 
measurements compared with that from utrophin for the actin-binding domains from filamin A 
(**p < 0.05), plectin (***p < 0.05), CH1 from utrophin (*p < 0.05), and CH2 from utrophin 
(****p < 0.05). (E) Comparison of measurements of relative bound fraction in cells with in vitro 
binding affinity measurements. The Kd for CH1 = 6 µM (Singh et al., 2014), the Kd for 
CH2 > 1000 µM (Singh et al., 2014), the Kd for flnA = 47 µM (Ruskamo and Ylänne, 2009), 
the Kd for plectin ≈ 120 µM, and the Kd for utrn = 13.8 µM (this study).
Many of these diseases are a consequence of single point 
mutations that can result in either loss of function (decreased affinity 
for F-actin) or gain of function (increased affinity for F-actin). For 
example, the K255E mutation in α-actinin-4 (Lee et al., 2008) and 
the M251T mutation in filamin C increase actin-binding affinity (Duff 
et al., 2011), while missense mutations to filamin A in PVNH 
decrease binding affinity (Iwamoto et al., 
2018). The K255E mutation to α-actinin-4 is 
associated with the disruption of an interac-
tion between a tryptophan on the CH1 
domain and a cation on CH2. This interac-
tion is highly conserved among CH1–CH2 
domains and is proposed to dominate inter–
CH domain interactions and affect affinity by 
latching the domains into a compacted or 
“closed” configuration (Bañuelos et al., 
1998; Galkin et al., 2010; Iwamoto et al., 
2018; Figure 1B). Disruption of this interac-
tion is proposed to allow the domains to 
adopt an open configuration upon binding 
to actin, reducing steric clash between CH2 
and F-actin and increasing actin-binding af-
finity (Galkin et al., 2010). Physiologically, 
such increases in actin-binding affinity can 
cause excessive bundling and cross-linking 
of the cytoskeleton, compromising cellular 
function (Weins et al., 2007; Ehrlicher et al., 
2015; Avery et al., 2017b) and resulting in 
changes to the physical properties of the cy-
toskeleton (Fletcher and Mullins, 2010; Yao 
et al., 2011; Moeendarbary and Harris, 
2014; Harris et al., 2018). Consequently, pre-
cise tuning of CH1–CH2 affinity for F-actin 
appears to be critical for proper organiza-
tion and function of the actin cytoskeleton.
Here, we focus on the actin-binding 
protein utrophin and show that its CH1–
CH2 domain affinity for F-actin can be 
both increased and decreased by pertur-
bations that affect the degree to which it 
can adopt an “open” or “closed” configu-
ration in solution and reach a bound state 
through displacement of CH2 upon actin 
binding. We find that mutations distinct 
from the well-studied cation–π interaction 
impacted the affinity of utrophin CH1–
CH2, showing that diverse modifications 
can alter the steric clash between CH2 
and F-actin and allow tuning of CH1–CH2 
domain affinity. We find that point muta-
tions at the CH1–CH2 interface and re-
placing the utrophin CH1–CH2 linker do-
main with an unstructured linker lead to 
increased affinity, while a polyethylene 
glycol (PEG) modification of the CH2 do-
main that adds molecular size leads to de-
creased affinity. These perturbations are 
consistent with a model in which the de-
gree to which the CH1 and CH2 domains 
can adopt “open” or “closed” conforma-
tions regulates affinity to F-actin. Interest-
ingly, we also find that the N-terminal re-
gion of CH1, which was recently shown to affect F-actin–binding 
affinity (Avery et al., 2017a; Singh et al., 2017; Iwamoto et al., 
2018), is sufficient to alter the subcellular localization of utrophin’s 
CH1–CH2 domain in live cells. The ability of small sequence 
changes in CH1–CH2 domains not only to increase and decrease 
affinity but also to alter subcellular localization provides new 
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insight into disease-associated mutations and how spatial organi-
zation of the actin cytoskeleton is regulated.
RESULTS
Measurement of CH1–CH2 domain binding in vitro and in 
live cells
The overall goal of this study is to understand how changes to a 
CH1–CH2 actin-binding domain alter its affinity to F-actin, using 
utrophin as an initial model. To characterize the binding of CH1–
CH2 domains to F-actin, we used two complementary approaches: 
1) traditional in vitro cosedimentation assays using purified proteins 
and 2) live cell assays in which the relative fraction of protein bound 
to the actin cytoskeleton is quantified. While cosedimentation is a 
standard method for obtaining bulk affinity measurements, a live-
cell assay offers a more rapid and convenient, if less quantitative, 
way to screen mutants for differences in enrichment on the actin 
cytoskeleton, as well as for localization to specific structures. We first 
sought to test whether CH1–CH2 binding assays in live cells would 
produce results consistent with traditional cosedimentation assays.
To measure the bound fraction of a fluorescent protein expressed 
in live cells, we developed a custom image analysis approach based 
on relative labeling of the actin cytoskeleton. Actin was imaged by 
expressing the actin-binding domain of utrophin, which is com-
monly used as a live-cell label of F-actin (Burkel et al., 2007), fused 
to green fluorescent protein (GFP). In a second fluorescence chan-
nel, the actin-binding domain of interest fused to mCherry was im-
aged. The average amount of the domain of interest bound to actin 
was then quantified using the utrophin channel to differentiate be-
tween bound and unbound populations (see Materials and Meth-
ods). An example showing the actin-binding domain of filamin A 
compared with utrophin ABD is given in Figure 1C.
We first quantified the binding of CH1 and CH2 domains alone 
in live cells and compared with previous measurements of CH1 and 
CH2 affinity. Affinity of tandem CH1–CH2 domains for F-actin is 
known to arise primarily from the CH1 domain, as CH2 alone cannot 
bind to actin (Singh et al., 2014). We separately expressed the 
minimal CH1 and CH2 domains from utrophin fused to mCherry 
(Supplemental Figure S1). The isolated CH1 domain of utrophin had 
a high relative bound fraction (0.55 ± 0.09, *p < 0.05; Figure 1D), 
although the isolated domain appeared partially insoluble, aggre-
gating within cells (Supplemental Figure S1, A and B), consistent 
with previous observations about its stability in vitro (Singh et al., 
2014). The isolated CH2 domain was soluble but distributed 
throughout the cytosol (Supplemental Figure S1C) with a low 
relative bound fraction (-0.27 ± 0.06, ****p < 0.05; Figure 1D), 
implying that it alone has minimal actin-binding activity. These 
measurements of relative bound fraction in live cells are consistent 
with in vitro affinity measurements for the isolated CH domains for 
utrophin (Figure 1E; Singh et al., 2014) and can be obtained rapidly 
for screening purposes.
Relative affinity of CH1–CH2 domains for F-actin can be 
detected in live cells
We next compared the binding of native CH1–CH2 domains in our 
live cell assay with cosedimentation affinity measurements. In 
tandem configurations, CH2 has been shown to act as a negative 
regulator of F-actin binding through a steric clash with the actin 
filament upon engagement of the CH1 with F-actin (Galkin et al., 
2010). To bind with high affinity, the CH1–CH2 conformation is 
thought to adopt an “open” rather than a “closed” conformation, 
where the steric interaction of the CH2 with F-actin is reduced 
(Galkin et al., 2010). Native tandem CH domains have been shown 
to crystalize in a range of different conformations, including an 
“open” state for the utrophin actin-binding domain (utrophin’s ABD 
1QAG; Keep et al., 1999; Figure 1B) and a “closed” state for plec-
tin’s ABD (1MB8; García-Alvarez et al., 2003; Figure 1B).
We measured the relative bound fractions of the CH1–CH2 
domains of utrophin (Supplemental Figure S1D), filamin A (Supple-
mental Figure S1E), and plectin (Supplemental Figure S1F) in live 
cells. We found that utrophin had the highest relative bound fraction 
(0.81 ± 0.02, Figure 1D), while plectin had the lowest (-0.09 ± 0.05, 
***p < 0.05, Figure 1D), characterized by a greater cytoplasmic 
signal (Supplemental Figure S1F). These measurements are consis-
tent with previous data showing that utrophin resides in an “open”’ 
conformation in solution, while plectin resides in a “closed” confor-
mation that presents a significant steric barrier to interactions with 
F-actin (García-Alvarez et al., 2003; Galkin et al., 2010; Lin et al., 
2011). To compare our relative bound fraction measurements in live 
cells directly with bulk affinity measurements, we purified plectin 
and utrophin ABDs and measured affinity to F-actin in cosedimenta-
tion assays (Figure 1E; Supplemental Figure S2). Utrophin’s ABD had 
a significantly higher binding affinity for actin (Kd = 13.8 µM) than 
that of the plectin construct, which showed little binding over the 
range of actin concentrations that we tested with our assay (Kd ≈ 120 
µM). Together, these results show that a wide range of CH1–CH2 
affinities can be captured by measuring relative bound fraction in 
live cells, though any differences in binding affinity due to actin iso-
forms could not be assessed.
Mutations targeting the inter-CH domain cation–π 
interaction increase the binding affinity of CH1–CH2 
domains from plectin but not utrophin
The “open” and “closed” model of tandem calponin homology 
domain binding to F-actin has focused primarily on the role of a 
conserved cation–π interaction at the CH1–CH2 interface that 
latches the CH domains into a “closed” configuration. Typically this 
interaction is between a highly conserved aromatic residue, such as 
tryptophan, on the CH1 and a lysine on the CH2 domain (Borrego-
Diaz et al., 2006). We wondered whether disrupting this interaction 
would broadly increase binding affinity, even of CH1–CH2 domains 
such as utrophin’s, which is already considered to be in an “open” 
configuration.
To test this, we made mutations to the CH2 domains of utrophin 
(K241E, Supplemental Figure S1G), filamin A (E254K, Supplemental 
Figure S1H), and plectin (K278E, Supplemental Figure S1I) that are 
predicted to lie at the interdomain interface and measured the 
resulting bound fractions in live cells (Figure 2A). Consistent with the 
“open” and “closed” model of CH1–CH2 binding, these mutations 
increased the binding of the filamin A (0.64 ± 0.05, p < 0.05) and 
plectin domains (0.62 ± 0.03, **p < 0.05) to F-actin, resulting in a 
bound fraction closer to that for the native utrophin CH1–CH2. 
However, the mutation of the equivalent residue on utrophin ABD 
had no effect on the apparent bound fraction, consistent with the 
idea that this domain already exists in an “open” conformation 
relative to filamin and plectin ABDs (Figure 1, A and B; 0.84 ± 0.02, 
p = 0.08; Lin et al., 2011). We made cosedimentation measurements 
of the plectin K278E mutant that confirmed that its bulk binding 
affinity increased significantly (Kd = 45.1 µM).
To test interdomain interactions in a different way, we measured 
melting temperature as a proxy for domain stability (Singh and 
Mallela, 2012; Singh et al., 2014; Avery et al., 2017a). As expected, 
the melting temperature of the plectin CH1–CH2 (Tm = 64.2 ± 0.4°C) 
was higher than that of the utrophin CH1–CH2 (Tm = 57.0 ± 0.4°C; 
Figure 2C), implying a more compact and stable conformation, 
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FIGURE 2: Binding affinity to F-actin depends on conformation and inter-CH domain 
interactions. (A) Relative bound fraction measurements for the mutants of plectin (K278E, 
**p < 0.05) and utrophin (K241E, p = 0.08). (B) Binding curves of actin-binding domains to 
F-actin. Low binding is observed for plectin over the range of concentrations tested, implying a 
low-affinity interaction. The mutation K278E restores binding affinity. (C) Melting temperatures 
for the actin-binding domain of plectin and the K278E mutant of plectin’s actin-binding domain.
while the plectin K278E mutation had a reduced melting tempera-
ture in comparison to those of the native domain (Tm = 58.2 ± 0.2°C; 
Figure 2C), consistent with reduced inter-CH domains.
Utrophin CH1–CH2 affinity is increased by alternate 
interface mutations that do not change solution “openness”
The mutation that targets the π–cation interaction reduced interdo-
main interactions for plectin’s CH1–CH2 domain and increased its 
affinity for F-actin but had no effect on utrophin’s CH1–CH2 domain. 
However, disease-associated mutations have been shown to change 
the affinity of tandem calponin homology domains by several orders 
of magnitude (Avery et al., 2017b), suggesting that other CH1–CH2 
interactions could impact binding affinity. To test this, we focused on 
utrophin’s CH1–CH2 and investigated the contribution of different 
parts of the ABD to actin binding affinity.
We introduced the point mutations Q33A and T36A to the CH1–
CH2 domain of utrophin, locations that are predicted to lie at the 
CH1–CH2 interface, and evaluated F-actin binding. In our live-cell 
assay, the relative bound fraction of this construct remained high 
(Figure 3A; 0.87 ± 0.05, p = 0.23), indicating a high actin-binding 
affinity. We then measured the mutant’s binding affinity in a 
cosedimentation assay and observed a significantly higher actin-
binding affinity (Kd = 0.4 µM, Figure 3B) than for the native utrophin 
CH1–CH2. Consistent with this increase in affinity, we measured a 
lower melting temperature (Tm = 54.9 ± 0.3°C, Supplemental Figure 
S2D) for the mutant CH1–CH2 compared with the native domain, 
indicating reduced structural stability. We speculated that destabili-
zation of CH1–CH2 interactions could increase binding affinity by 
two mechanisms. First, the mutations could shift the solution state 
of the domain to be “more open”—further reducing steric interac-
tions upon initial binding to F-actin. Second, they could make 
transitioning to the bound state more favorable—in the absence of 
changes in solution openness.
To investigate whether the interface mutations altered physical 
properties of CH1–CH2 domains, we measured radius of gyration 
(Rg), which captures CH1–CH2 solution “openness,” using small-
angle x-ray scattering (SAXS; Hura et al., 2009; Supplemental Figure 
S3; see Materials and Methods). The plectin ABD construct had the 
smallest Rg (22.0 Å), suggesting a “closed” conformation in solu-
tion, while the Rg of utrophin ABD was larger 
(24.0 Å). The utrophin Q33A T36A mutant 
had an Rg similar to that of WT utrophin 
(23.5 Å), suggesting that the solution “open-
ness” of the domains was similar. However, 
our SAXS data also indicated a slight in-
crease in flexibility of the domain.
Förster resonance energy transfer and 
single-molecule measurements reveal 
changes in utrophin CH1–CH2 mutant 
binding kinetics
WT utrophin has been shown to undergo a 
conformational change when binding to F-
actin through an induced-fit mechanism (Lin 
et al., 2011). We sought to test whether 
there was a similar structural change of the 
Q33A Q36A mutant upon binding to F-ac-
tin. We compared opening of the domains 
using Förster resonance energy transfer 
(FRET) in the presence and absence of F-
actin. To do this, we installed an N-terminal 
GFP as the donor and engineered a single 
cysteine at position 168 on the CH2, which we chemically labeled 
with Alexa 555 maleimide as an acceptor fluorophore. Interestingly, 
both the WT and mutant domains showed a decrease in FRET in the 
presence of F-actin (Figure 3C), suggesting that both undergo an 
induced fit upon binding to actin.
If the mutant utrophin ABD has similar solution “openness” to 
WT utrophin ABD based on SAXS measurements and similar reduc-
tion in FRET upon F-actin binding, what could give rise to the differ-
ence in bulk affinity? We wondered whether comparing binding 
kinetics of the two ABDs could provide further insight. We mea-
sured the dwell times of single-molecule binding events of WT utro-
phin and the Q33A T36A mutant with TIRF microscopy (Figure 3D; 
Supplemental Figure S4). Interestingly, the mean dwell time of bind-
ing events from the Q33A T36A mutant was ∼10-fold longer than 
that of the WT binding domain (τQ33AT36A = 8.49 ± 0.14 s; τWT = 0.96 
± 0.01 s). However, the difference in binding affinity measured using 
cosedimentation was ∼30-fold, suggesting a difference in on-rate of 
approximately threefold. In summary, the Q33A T36A mutations af-
fected both the on-rate and off-rate of binding.
Loss of utrophin CH1–CH2 affinity due to N-terminal 
truncation can be compensated for by the incorporation of 
CH1–CH2 interface mutations
The N-terminal flanking region varies significantly between CH1–
CH2 domain proteins, both in sequence and in length (Singh et al., 
2017; Iwamoto et al., 2018). This region has recently been shown to 
be important for actin-binding affinity, as its deletion in either utro-
phin (Singh et al., 2017) or ß-spectrin (Avery et al., 2017a) reduces 
actin binding. Interestingly, the N-terminal flanking region from 
filamin B is significantly shorter than that from ß-spectrin, despite 
the relatively high reported binding affinity (Kd ∼ 7 µM) of filamin B’s 
ABD for F-actin (Sawyer et al., 2009).
To confirm the importance of the N-terminal flanking region in 
CH1–CH2 affinity for F-actin, we truncated residues 1–27 of the 
utrophin ABD and expressed the remaining CH1–CH2 domain in 
live cells (Figure 3A; Supplemental Figure S5A). This construct (Δ-n-
term) had a low bound fraction (0.25 ± 0.03, p < 0.05), indicating a 
reduced binding affinity to F-actin compared with that of the native 
utrophin CH1–CH2. This is consistent with previous results reporting 
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FIGURE 3: Mutations to the interdomain interface or interdomain linker region result in an 
increase in binding affinity. (A) Relative bound fraction measurements for interdomain interface 
mutants (p = 0.24), n-terminal deletion (p < 0.05), n-terminal deletion with Q33A T36A (p = 
0.54), the actin-binding domain from filamin B (p = 0.62), and a chimera of the interdomain 
linker from filamin A and utrophin’s CH domains (p = 0.89). (B) Binding curves for the Q33A 
T36A mutation (black, Kd = 0.4 µM). The binding fit for WT utrn is shown in green for 
comparison. (C) The FRET ratio of domains in buffer and in the presence of actin (WT utrophin 
ABD shown in green and Q33A T36A shown in black). (D) Single molecule–binding dwell time 
histograms. (E) Binding curves for Δ-nterm (orange, Kd = 31.4 µM) and Δ-nterm Q33A T36A 
(magenta, Kd = 7.1 µM). (F) Binding curves for the utrn-fln-linker chimera (gray, Kd = 0.7 µM). 
The binding fit for WT utrophin ABD is shown in green for comparison. (G) Melting temperature 
measurements for the interdomain linker mutant and the interdomain interface mutant of 
utrophin’s actin-binding domain.
the importance of this region for actin- 
binding affinity (Avery et al., 2017a; Singh 
et al., 2017; Iwamoto et al., 2018).
We wondered whether it would be pos-
sible to compensate for the loss in binding 
affinity by modifying the inter-CH domain 
interface of the Δ-n-term construct, as 
demonstrated above. To test this idea, we 
introduced the mutations Q33A T36A, 
which increased the affinity of the native 
utrophin CH1–CH2 domain into the n- 
terminal truncation construct (Δ-n-term 
Q33A T36A; Figure 3A). Remarkably, this 
mutation restored the bound fraction of 
the mutant Δ-n-term to F-actin in live cells 
(0.79 ± 0.03, p = 0.54, Figure 3A, Supple-
mental Figure S5B). Consistent with this, 
the incorporation of mutations into the 
inter-CH domain interface recovered the 
binding affinity of the n-terminal truncation 
as measured by cosedimentation (Figure 
3E; Kd Δ-n-term = 31 µM; Kd Δ-n-term 
Q33A T36A = 7 µM). These findings sug-
gest that some mechanisms controlling 
CH1–CH2 affinity, including contributions 
from inter-CH domain interactions and the 
N-terminal region, contribute to affinity in 
a separate and additive manner.
Utrophin CH1–CH2 interdomain linker 
structure affects binding affinity
Like the N-terminal flanking region, the in-
terdomain linker region has a high level of 
sequence and structural diversity among 
native CH1–CH2 domain–containing pro-
teins. The linker can be unstructured, as in 
the case of filamin and plectin (not resolved 
in the crystal structures of filamin A 2WFN, 
Ruskamo and Ylänne, 2009, or plectin 
1MB8, García-Alvarez et al., 2003), or it can 
be helical, as in the case of utrophin (1QAG, 
Keep et al., 1999) and dystrophin (1DXX, 
Norwood et al., 2000). We postulated that 
the interdomain linker region could have a 
role in regulating CH1–CH2 domain “open-
ness” in solution and thereby its affinity to 
F-actin. To test this, we generated chimeras 
containing the CH1 and CH2 domains from 
utrophin but the linker region from filamin 
A. In our live-cell assays, this chimeric pro-
tein had a high relative bound fraction (0.80 
± 0.07, p = 0.89; Figure 3A), indicating a 
high affinity for F-actin. We next expressed 
and purified this construct and found that 
the actin-binding affinity based on cosedi-
mentation was significantly higher (Kd = 0.7 
µM; Figure 3F) than that of the WT utrophin 
CH1–CH2. We also found that the chimeric 
protein had a significantly lower melting 
temperature (Tm = 50.5 ± 0.4°C; Figure 3G), 
indicating that the filamin A unstructured 
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linker caused a “more open” configuration of the tandem CH do-
main in solution than the WT utrophin CH1–CH2.
To further test the effect of the linker on properties of the 
CH1–CH2, we measured the radius of gyration (Rg) and flexibility 
of the linker chimera CH1–CH2 using SAXS (Hura et al., 2009; 
Supplemental Figure S3; Materials and Methods). Compared 
with the “closed” plectin CH1–CH2 domain (Rg = 22 Å) and 
“open” utrophin CH1–CH2 domain (Rg = 24 Å), the utrophin–
filamin-linker chimera had the largest Rg of the constructs we 
tested (41 Å), indicating that the unstructured linker from filamin 
A allowed the domain to adopt a conformation with a large 
separation between the CH1 and CH2 in solution. This construct 
was also the most flexible, potentially reducing any steric clash 
between the CH2 and actin filament upon binding, resulting in a 
higher affinity for F-actin.
Increasing the steric interaction of utrophin CH2 domain 
with F-actin can decrease F-actin–binding affinity
As seen in our measurements above and in previous studies (Galkin 
et al., 2010), “opening” of the CH1–CH2 interface is believed to 
reduce steric clash with the actin filament and provide increased 
access to the F-actin surface for CH1. We wondered whether it 
would be possible to reduce the F-actin affinity of CH1–CH2 
domains that are in an “open” configuration in solution (e.g., native 
utrophin CH1–CH2, disease-associated gain-of-function mutants, 
utrophin interface mutants, or utrophin–filamin-linker chimeras) by 
modifying the CH2 domain to increase steric clash. Because CH2 
alone has little or no binding interaction with F-actin (Figure 1D), we 
postulated that its steric interaction with actin could be increased by 
adding biologically inert bulk that simply increased the molecular 
size of the domain.
We increased the size of the CH2 domain of the WT utrophinn by 
conjugating a small PEG molecule to the surface of the domain 
(Figure 4A). Specifically, we mutated a serine, S158, to cysteine and 
performed a conjugation reaction with maleimide-750Da PEG, 
which has an approximate Rg of 1 nm. We found that the unconju-
gated mutant had a binding affinity similar to that of WT utrophin 
CH1–CH2 (Kd = 12.5 µM, Figure 4B), but the PEG-conjugated 
utrophin CH1–CH2 had a reduced binding affinity (Kd = 53.8 µM, 
Figure 4B). This result highlights that simply increasing the physical 
size of CH2 can reduce gains in affinity that arise from “open” 
conformation domains, supporting the idea that the CH2 steric 
clash with F-actin indeed modulates CH1–CH2 affinity.
CH1–CH2 domain subcellular localization is affected by the 
N-terminal region, independent of affinity
Our live-cell assay for CH1–CH2 binding allows us to screen not only 
for binding affinity but also for subcellular localization to different 
actin structures. We quantified differences in localization by calculat-
ing the correlation coefficients relative to native utrophin CH1–CH2 
and by measuring the bound amounts of proteins on different actin 
structures (e.g., stress fibers vs. peripheral actin networks). We first 
examined the utrophin–filamin CH1–CH2 linker chimera and found 
that its subcellular localization differed significantly from that of the 
WT utrophin CH1–CH2 domain. Specifically, it had a low correlation 
coefficient over the whole actin cytoskeleton (0.54 ± 0.04, p < 0.05, 
Figure 5A) and was comparatively depleted from the cell periphery 
(Supplemental Figure S5). However, as reported above, the CH1–
CH2 linker chimera affinity was significantly higher than that of the 
WT utrophin ABD. This large difference in overall affinity makes it 
difficult to conclusively decouple the contributions of overall affinity 
and specificity in subcellular localization to different actin structures.
To compare subcellular localization of different CH1–CH2 
domains with similar affinity, we turned to the utrophin ABD N-
terminal truncation with interface mutations that we introduced 
previously (Δ-n-term utrn Q33A T36A). Interestingly, the subcel-
lular localization of the mutant was significantly different from 
that of the WT utrophin ABD (Figure 5B; Supplemental Figure 
S6). The Δ-n-term Q33A T36A mutant displayed a moderate 
correlation with the WT utrophin ABD over the whole actin cyto-
skeleton (0.87 ± 0.03). Subcellularly, this mutant was distributed 
evenly on stress fibers and focal adhesions, while the WT utro-
phin CH1–CH2 was comparatively more enriched in focal adhe-
sions (Figure 5, C and D).
Finally, we investigated the subcellular localization of filamin B’s 
CH1–CH2 domain, which has a short N-terminal region and a Kd = 
7 µM, which is of the same order as WT utro-
phin ABD (Kd = 13.8 µM). Surprisingly, this 
domain showed preferential localization to 
stress fibers and was comparatively reduced 
at focal adhesions (Figure 5, C and D), simi-
larly to that of the utrophin construct with 
N-terminal truncation (Δ-n-term Q33A 
T36A). These differences in localization were 
not a result of differences in the dynamics of 
the proteins as measured by fluorescence 
recovery after photobleaching (FRAP; 
Supplemental Figure S7A), indicating that 
the N-terminal region may play a key role in 
modulating specificity of CH1–CH2 do-
mains for different actin structures, indepen-
dent of bulk differences in actin-binding 
affinity and dynamics.
DISCUSSION
Diseases involving actin-binding proteins 
with CH1–CH2 mutations that exhibit a gain 
of function (increased actin-binding affinity) 
are associated with increased “openness” 
of the domains. This often involves the 
FIGURE 4: Binding affinity of CH1–CH2 to F-actin can be reduced by increasing CH2 size. 
(A) Surface model of the actin-binding domain of utrophin (1QAG). The F-actin–binding surface 
on CH1, ABS2 (Iwamoto et al., 2018), is shown in green, and residue S158 on CH2 is shown in 
red, which was mutated to cysteine and used for PEG conjugation. (B) Binding curves for the 
utrophin S158C mutant (green) and the PEG750-conjugated mutant (magenta). This size 
increase caused a change in binding affinity from Kd = 12.5 µM to Kd = 53.8 µM.
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FIGURE 5: The N-terminal flanking region plays a role in CH1–CH2 localization to different actin 
structures. (A) Measurements of whole-cell correlation coefficients for WT utrophin ABD, 
utrophin–filamin-linker (*p < 0.05), Δ-nterm (**p < 0.05), Δ-nterm Q33A T36A (***p < 0.05), and 
filamin B (****p < 0.05) relative to WT utrophin ABD. (B) Measurement of protein-binding density 
on different actin structures (stress fibers and focal adhesions) shows significant differences in 
binding localization for both the Δ-nterm Q33A T36A construct (magenta, *p < 0.05) and the 
CH1–CH2 from filamin B (blue, **p < 0.05). (C) Representative images of the different 
constructs. (D) Line scans sectioning a stress fiber terminating in a focal adhesion showing the 
intensity in each channel and the density of the construct of interest (magenta) across the line 
scan. Scale bars are 10 µm.
disruption of a conserved cation–π interaction that is proposed to 
dominate inter-CH domain interactions and hold the two globular 
CH domains in a compact configuration.
Consistent with this, we found that disruption of the conserved 
cation–π interaction increased the binding affinity of plectin to be 
more like that of utrophin, which is thought to reside in an “open” 
configuration. By making chimeras of utro-
phin’s CH1 and CH2 with the linker region 
from filamin A, we have shown that the 
interdomain linker region can impact bind-
ing affinity by altering the “openness” of 
CH1 and CH2. Previous work has compared 
chimeras prepared from the CH domains of 
utrophin and the interdomain linker region 
of dystrophin, which did not significantly 
change binding affinity (Bandi et al., 2015). 
Importantly, however, the linkers from 
utrophin and dystrophin both have a helical 
structure, which might not be expected to 
alter domain “openness.” On introducing 
the unstructured linker from filamin A, we 
observed a large increase in binding affinity. 
In this configuration, the CH2 can presum-
ably move away more freely from F-actin, 
reducing any possible steric interactions 
with the filament that would hinder CH1 
binding. This increased “openness” is con-
sistent with the large Rg of the chimera in 
solution observed in our SAXS measure-
ments. Furthermore, mutations to the linker 
region of utrophin’s native CH1–CH2 that 
are predicted to destabilize its helical struc-
ture had behavior similar to that of the 
filamin linker–utrophin chimera when ex-
pressed in cells (Supplemental Figure S5C).
If a steric clash between CH2 and F-actin 
is reduced when CH1–CH2 domains are in 
“open” configurations in solution, then in-
creasing the steric clash should reduce bind-
ing affinity. We test this idea directly by add-
ing size to the CH2 domain and measuring 
binding to F-actin. After conjugating a bio-
chemically inert PEG molecule (Rg ∼ 1 nm) to 
the CH2 domain, we find that overall affinity 
of the domain is reduced approximately five-
fold. Interestingly, this concept could present 
a potential therapeutic approach to diseases 
that result in gain of actin-binding function, 
where a molecule of a specific size would tar-
get the CH2 domain in order to increase the 
steric interaction between CH2 and F-actin, 
thereby reducing binding affinity. The novelty 
of this approach is that the interaction be-
tween CH1 and F-actin itself does not need 
to be disrupted, meaning that overall affinity 
can be reduced without completely abolish-
ing affinity by blocking or antagonizing the 
CH1–to–actin binding interface.
Interestingly, we found that additional 
mutations to the CH1–CH2 interface of 
utrophin distinct from the well-studied 
cation–π interaction caused an increase in 
actin-binding affinity without altering its solution “openness.” In 
our measurements, WT utrophin ABD and the Q33A 36A mutant 
had similar Rg values and both underwent a conformational change 
when binding to actin, as measured by FRET. These observations 
suggest that mutations to the inter-CH domain interface make it 
easier for the protein to undergo a conformation change when 
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binding, characterized by an approximately threefold increase in 
on-rate, while not having a dramatic effect on their “openness” in 
solution. Furthermore, we observed a change in binding off-rate of 
∼10-fold for the Q33A T36A mutant. We speculate that the large 
difference in off-rate implies that reduced inter-CH domain interac-
tions allow the domain to adopt a high-affinity state when bound to 
F-actin, potentially through reduced steric interactions between 
CH2 and F-actin. This notion is consistent with measurements that 
have shown that the CH domains from dystrophin and utrophin can 
adopt a range of conformations in solution, only some of which are 
potentially compatible with F-actin binding (Fealey et al., 2018).
Finally, we observed that the N-terminal flanking region before 
CH1 appears to affect CH1–CH2 domain localization to specific ac-
tin structures, independent of binding affinity. By truncating the N-
terminal flanking region of utrophin (which reduces affinity) and in-
troducing CH1–CH2 interface mutations (which increase affinity), we 
were able to create a construct with binding affinity similar to that of 
WT utrophin CH1–CH2 (Figure 3E; Figure 5A) but with significantly 
different subcellular localization (Figure 5, B–D). The change in local-
ization is not the result of kinetic differences in binding, which have 
been proposed for the localization of myosin to the rear of migra-
tory cells (Maiuri et al., 2015), as the kinetics of the two ABDs were 
similar when measured by FRAP (Supplemental Figure S7A).
These results indicate that CH1–CH2 domains could influence 
both the binding and the localization of full-length proteins that con-
tain them. For example, the isoforms filamin A and filamin B have 
high sequence identity both across both the full-length protein 
(∼68%) and within the CH1–CH2 domain (∼75%), but the minimal ac-
tin-binding domains have different affinities for F-actin and different 
localizations, as well as different cellular functions. Filamin A plays a 
critical role in maintaining cortical mechanical integrity, but the pres-
ence of filamin B is not sufficient to compensate for the absence of 
filamin A in blebbing melanoma cells (Biro et al., 2013). Filamins also 
function as signaling scaffolds, interacting with more than 30 different 
proteins. Genetic mutations of each isoform are linked with specific 
filaminopathies suggesting distinct protein interactions between iso-
forms (Feng and Walsh, 2004). Many genetic mutations that result in 
filaminopathies are clustered within the actin-binding domain, and it 
is interesting to speculate that changes in localization could also re-
sult in differences in intracellular signaling. One region of increased 
diversity between these proteins is in the N-terminal flanking region. 
When we express the actin-binding domains from different filamin 
isoforms in live cells, we observe different binding characteristics. A 
chimera of the filamin A N-terminal flanking region with CH1 and 
CH2 domains from filamin B partly increased its subcellular localization 
to focal adhesions, but some differences in localization (compared 
with WT utrophin ABD) could still be observed (Supplemental Figure 
S8). This result implies that the N-terminal flanking region is indeed 
important for affinity, but also for subcellular localization of the do-
main. The combination of inter-CH domain and N-terminal interac-
tions therefore creates a versatile range of actin-binding properties, 
including affinity to F-actin and localization to specific actin structures. 
While CH1–CH2 domains from different proteins share similarities in 
structure and sequence, small differences can be significant, affecting 
both binding affinity and localization and highlighting why disease-
associated point mutations can have such a detrimental impact.
MATERIALS AND METHODS
Cell culture
HeLa and HEK293T cells were cultured at 37°C in an atmosphere of 
5% CO2 in air in DMEM (Life Tech, #10566024) supplemented with 
10% fetal bovine serum (Life Tech, #16140071) and 1% penicillin–
streptomycin (Life Tech, #15140122). HEK293T cells were passaged 
using 0.05% trypsin and HeLa cells with 0.25% trypsin.
Generation of constructs and cell lines
To visualize the localization of different constructs with respect to WT 
utrophin ABD, single-expression and bicistronic-expression plasmids 
were generated for transient transfection, and two separate virus 
plasmids were generated for creating stable cell lines. PCS2+ GFP-
UtrCH was a gift from William Bement (University of Wisconsin; 
Addgene plasmid #26737; http://n2t.net/addgene:26737; 
RRID:Addgene_26737; Burkel et al., 2007). cDNA for generating con-
structs to image WT CH domains was either amplified using PCR or 
synthesized directly (Integrated DNA Technologies) and inserted into 
the desired vector using Gibson assembly. The actin-binding domain 
of human filamin A corresponds to residues 1–278, and we used a 
construct similar to that of García-Alvarez et al. (2003) for the actin-
binding domain of plectin a.a. 60–293. For dual expression, a cleav-
able peptide was introduced into the c terminus of GFP-UtrCH, fol-
lowed by mCherry fused to the actin-binding domain of interest (Kim 
et al., 2011). Transient transfections were performed using Effectene 
(Qiagen, #301425) following the manufacturers stated protocol and 
imaged 24 h after transfection. To generate stable cell lines, GFP-
UtrCH and the construct of interest fused to mCherry were cloned 
into lentiviral plasmid pHR. Lentiviruses were then generated through 
second-generation helper plasmids and transfected into HEK293 
cells for packaging. Lentiviral supernatants were collected 48–72 h 
after transfection, filtered using a 0.4-µm filter, and used directly to 
infect the target cell line in a 1:1 ratio with normal culture media.
Protein purification and labeling
Actin was purified from rabbit muscle acetone powder (Pel Freez 
Biologicals, #41995-1). Actin was stored in monomeric form in G-
buffer (2 mM Tris-Cl, pH 8.0, 0.2 mM ATP, 0.5 mM TCEP, 0.1 mM 
CaCl2) at 4°C. Petm60-Utr261 was a gift from Peter Bieling (Max 
Planck Institute of Molecular Physiology, Dortmund, Germany; 
Bieling et al., 2017). WT utrophin ABD and its associated mutants 
were expressed recombinantly in Escherichia coli BL21 (DE3) pLysS 
(Promega, #L1191) and purified using affinity chromatography fol-
lowed by gel filtration. Proteins were stored in 20 mM Tris-Cl, pH 7.5, 
150 mM KCl, 0.5 mM Tris(2-carboxyethyl)phosphine (TCEP) (GF-buf-
fer) and 0.1 mM EDTA in the presence of 20% glycerol. Utrophin ABD 
and plectin ABD sequences included a KCK linker (GGSGKCKSA) on 
the C terminus for labeling. Proteins were labeled using either Alexa 
555 and Alexa 488 maleimide dye (Life Technologies, #A22287 and 
#A20346) at the cysteine site in the KCK linker region. Briefly, proteins 
were reduced in 5 mM TCEP for 30 min and then buffer-exchanged 
over a desalting column into GF buffer without TCEP. Labeling was 
performed at 4°C with an approximately fivefold molar excess of dye 
overnight. The reaction was then quenched with dithiothreitol (DTT) 
and the excess dye removed by gel filtration. A typical labeling ratio 
was ∼75%. The actin-binding domain of plectin was purified and la-
beled using the same method as for utrophin, but with a reduced 
labelling time to yield a similar labelling ratio to utrophin. For PEG- 
conjugated utrophin constructs, a similar purification and labeling 
strategy was used, but with EGFP fused to the n-terminus of the do-
main so that single cysteine mutants could be used for labeling. PEG-
maleimide (750 Da; Rapp Polymere) was conjugated to cysteine resi-
dues on utrophin using the same labelling strategy described above.
Spinning disk confocal imaging
Fluorescent proteins were imaged using the following excitation 
and emission: GFP was excited at 488 nm, and emission was 
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collected at 525 nm; mCherry was excited at 543 nm and emission 
was collected at 617 nm. Live imaging experiments were performed 
in normal cell culture media using an OKO Labs microscope stage 
enclosure at 37°C in an atmosphere of 5% CO2. Cells were imaged 
on glass-bottomed eight-well chambers that had been coated with 
10 µg/ml fibronectin. Dual-color images were used to measure 
differences in protein binding and localizations (Belin et al., 2014).
Relative bound fraction measurements and image 
difference mapping
A custom-written MatLab routine was used to calculate the 
relative bound fractions of different actin-binding domains, the 
difference maps, and correlation coefficients. Briefly, images of 
cells expressing GFP-utrn were thresholded and binarized to gen-
erate masks of the whole cell and actin cytoskeleton. Holes within 
the binary image mask were filled and this was used as an outline 
of the cell footprint. To generate a mask for the unbound fraction, 
the complementary image of the actin mask was taken, which in-
cluded pixels only within the cell footprint (Figure 1C). Average 
pixel intensity measurements I( ) were then made using the two 












In some instances of very low binding, RBF was less than zero. This 
arises due to the geometry of the cell, where higher intensities are 
gathered from the cell body, where there is more cytoplasmic sig-
nal, in comparison to actin-rich regions, which are often thin and 
flat at the cell periphery. RBF is a convenient measure when averag-
ing over many cells to rule out large contributions from cell geom-
etry or F-actin abundance. For comparing the localization of differ-
ent actin-binding domains, the same masking method was used to 
make measurements of intensity of the CH1–CH2 of interest and 
WT utrophin ABD. The images were normalized to their maximum 
values and the WT utrophin ABD image values subtracted from the 
CH1–CH2 image to give the difference map (Figure 5B). Pearson’s 
correlation coefficient was calculated from the image values to 
quantify whole-cell differences in localization. To measure the rela-
tive amounts of protein bound to different actin structures (stress 
fibers and focal adhesions), local pixel value measurements were 
made, background was subtracted, and measurements were nor-
malized to the F-actin abundance within that structure (using the 
WT utrophin ABD channel as a reference for F-actin).
FRAP measurements
To measure the recovery rates of different proteins in live cells, we 
performed FRAP experiments. Measurements were made using a 
Zeiss LSM 880 NLO Axio Examiner using a 20× dipping objective. 
Cells were plated onto 6-cm plastic-bottomed dishes (Falcon) 24 h 
before experiments. Cells were imaged for one frame; a small cir-
cular region ∼1 µm in diameter was then bleached and imaged 
with a frame rate of 0.95 s/frame to monitor the fluorescence 
recovery. Images were analyzed using the approach of Phair 
et al. (2003). To calculate the proteins’ dynamics, the initial rate of 
recovery was measured, which was independent of the bleaching 
fraction or immobile fraction.
Circular dichroism and melting temperature measurements
Circular dichroism (CD) wavelength scans (250–200 nm) and 
temperature melts (25–80°C) were carried out using an AVIV Model 
410 CD spectrometer. Temperature melts monitored absorption sig-
nal at 222 nm and were carried out at a heating rate of 4°C/min. 
Protein samples were prepared at ∼7.5 µM in phosphate-buffered 
saline in a 0.1-cm cuvette. Melting temperature data were fitted 
using the equation









where Tm is the melting temperature, b is the slope parameter, and 
T is the temperature.
Small-angle x-ray scattering measurements
Proteins were exchanged into SAXS buffer (20 mM Tris-Cl, pH 7.5, 
150 mM KCl, 0.5 mM TCEP and 0.1 mM EDTA) using a 10-kDa 
MWCO Zeba spin desalting column (Thermo Scientific). Corre-
sponding blanks were prepared by diluting flow-through from spin 
columns into appropriate buffers at the same dilution. Samples were 
prepared at concentrations of 3–8 mg/ml. SAXS measurements 
were made at the SIBYLS 12.3.1 beamline at the Advanced Light 
Source. The light path was generated by a superbend magnet to 
provide a 1012-photons/s flux (wavelength 1 Å) and detected on a 
Pilatus 3 2M pixel array detector. Data from each sample were 
collected multiple times with the same exposure length, generally 
30 frames with a frame rate of 0.3 s per frame. Data were analyzed 
using the Scatter software.
Actin filament–binding assay
Filamentous actin was prepared by polymerizing β-actin at 162 µM 
for 1.5 h at room temperature. Various concentrations of F-actin 
were then combined with a constant concentration of fluorophore-
labeled actin-binding domain (either 100 nM for utrn ABD, utrn-
fil-linker ABD, utrn Q33A T36A ABD, or 1 µM plectin ABD and 
plectin K278E ABD) in Buffer F. Substoichiometric concentrations 
of actin-binding domains were used in all experiments, so that the 
assumption [F-actin]total ≈ [F-actin]free was valid. After incubation at 
room temperature for 30 min, F-actin and bound actin-binding 
domain were pelleted at 150,000 × g for 60 min at 4°C. The super-
natants were then collected, and unbound actin-binding domain 
fluorescence intensity was analyzed using a fluorimeter (Biotek 











where I is the normalized bound fraction, α is the binding stoichiom-
etry, [F-actin] is the actin concentration, and kD is the dissociation 
constant. For the case of low-affinity actin-binding domains, the 
plectin mutant K278E and utrn-S158C-PEG, α was set equal to 1.
FRET measurements
To investigate structural changes of CH1–CH2 domains, we used 
FRET between GFP fused to the n-terminus of the CH1–CH2 
domain of interest and Alexa 555 maleimide on CH2. S168 was 
mutated to cysteine for labelling with Alexa 555 maleimide (Life 
Tech) as described above. FRET measurements were made on a 
fluorescence plate reader in the presence or absence of F-actin 
(32 µM). FRET was determined at an excitation wavelength of 
488 nm and an emission wavelength of 575 nm. Donor and acceptor 
bleedthrough signals were collected under identical conditions 
with the GFP-CH1–CH2 domain lacking the acceptor fluorophore 
Volume 30 December 15, 2019 Steric CH1–CH2 regulation | 3121 
and the free Alexa 555 dye, respectively. Bleedthrough signals were 
subtracted from the FRET construct fluorescence.
Single-molecule measurements
Single-molecule measurements were made as described previously 
(Hansen et al., 2013; Hayakawa et al., 2014). Briefly, we measured 
the off-rate from binding dwell-time histograms using single-mole-
cule TIRF microscopy (Supplemental Figure S4). F-actin filaments 
were polymerized for 1 h to a final concentration of 5 µM at room 
temperature and then tethered to pegylated glass surfaces 
(5% biotin, peg 2k [Rapp Polymere]; Bieling et al., 2010). Surfaces 
were assembled in a flow chamber configuration (Bieling et al., 
2010, 2017) and incubated with streptavidin followed by biotin–
phalloidin (Life Technologies) to create a functional surface for 
tethering actin filaments. The final buffer for imaging contained 
10 µg/ml β-casein (Sigma) with 0.05 nM of binding protein to obtain 
single-molecule dilutions in f-buffer. Images were acquired with 
TIRF microscopy at a frame rate of 100 ms/frame for WT utrn. Owing 
to the slower unbinding kinetics of the mutant Q33A T36A, a frame 
rate of 600 ms/frame was used. Single particles were tracked using 
TrackNTrace (Stein and Thiart, 2016) and analyzed with a custom-
written MatLab routine.
Statistics
Error bars represent standard error for relative bound fraction 
and FRAP measurements. Confidence intervals for fitted data are 
reported melting temperature measurements. Statistical signifi-
cance was determined by a two-tailed Student’s t test and assumed 
significant when p < 0.05.
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